Literature DB >> 10473261

Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

K Tsou1, K Mackie, M C Sañudo-Peña, J M Walker.   

Abstract

Localization of cannabinoid CB 1 receptors on GABAergic interneurons in the rat hippocampal formation was studied by double-labeling immunohistochemistry with confocal microscopy. Virtually all CB1-immunoreactive neurons (95%) are GABAergic. CB 1 fluorescence showed a punctate pattern. In contrast, the GABA fluorescence was distributed homogeneously, suggesting that while CB 1 receptors and GABA exist in the same cells they are not localized in the same subcellular compartments. Although virtually all CB1 neurons were GABAergic, many GABAergic neurons did not contain CB1 receptors. GABAergic interneurons in the hippocampal formation can be further divided into subpopulations with distinct connections and functions, using cell markers such as neuropeptides and calcium binding proteins. CB1 receptors were highly co-localized with cholecystokinin and partially co-localized with calretinin and calbindin, but not with parvalbumin. This suggests that cannabinoids may modulate GABAergic neurotransmission at the synapses on the soma and at synapses on the proximal dendrites of the principal neurons, as well as at synapses on other GABAergic interneurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473261     DOI: 10.1016/s0306-4522(99)00086-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  101 in total

1.  Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.

Authors:  I Katona; B Sperlágh; A Sík; A Käfalvi; E S Vizi; K Mackie; T F Freund
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

Review 2.  A possible mechanism for the effect of neuromodulators and modifiable inhibition on long-term potentiation and depression of the excitatory inputs to hippocampal principal cells.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2003-07

3.  Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.

Authors:  Katherine W Sayers; Peter T Nguyen; Robert E Blair; Laura J Sim-Selley; Robert J DeLorenzo
Journal:  Epilepsia       Date:  2012-04-17       Impact factor: 5.864

4.  Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.

Authors:  Önder Albayram; Stefan Passlick; Andras Bilkei-Gorzo; Andreas Zimmer; Christian Steinhäuser
Journal:  Pflugers Arch       Date:  2016-01-07       Impact factor: 3.657

5.  Sex-Specific Disruption of Distinct mPFC Inhibitory Neurons in Spared-Nerve Injury Model of Neuropathic Pain.

Authors:  Andrea F Jones; Patrick L Sheets
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

Review 6.  Defined types of cortical interneurone structure space and spike timing in the hippocampus.

Authors:  Peter Somogyi; Thomas Klausberger
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

7.  Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat.

Authors:  Anushka V Goonawardena; Lianne Robinson; Robert E Hampson; Gernot Riedel
Journal:  Learn Mem       Date:  2010-09-28       Impact factor: 2.460

Review 8.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Developmental alteration of endocannabinoid retrograde signaling in the hippocampus.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurophysiol       Date:  2009-12-09       Impact factor: 2.714

10.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.